# XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)

> **NCT01120379** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 5034 (actual)

## Conditions studied

- Chronic Coronary Occlusion
- Vascular Disease
- Myocardial Ischemia
- Coronary Artery Stenosis
- Coronary Disease
- Coronary Artery Disease
- Coronary Restenosis

## Interventions

- **DEVICE:** XIENCE V® EECSS

## Key facts

- **NCT ID:** NCT01120379
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-12
- **Final completion:** 2013-12
- **Target enrollment:** 5034 (ACTUAL)
- **Last updated:** 2015-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01120379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01120379, "XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01120379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*